Drug intelligence / Profile preview

C26-A6

Development stage
Preclinical
Lead developer
Virginia Commonwealth University
Modality
Small Molecules
01

Overview

C26-A6: sourced facts only. name: "The objective is to evaluate the therapeutic efficacy of the combination of C26-A6 and MYCi975, small molecule inhibitors of AEG-1 and MYC, respectively, for HCC." [DOI:10.1158/1538-7445.am2025-6935]; target: "The objective is to evaluate the therapeutic efficacy of the combination of C26-A6 and MYCi975, small molecule inhibitors of AEG-1 and MYC, respectively, for HCC." [DOI:10.1158/1538-7445.am2025-6935]; developer: "Virginia Commonwealth University, Richmond, VA." [DOI:10.1158/1538-7445.am2025-6935]; modality: "The objective is to evaluate the therapeutic efficacy of the combination of C26-A6 and MYCi975, small molecule inhibitors of AEG-1 and MYC, respectively, for HCC." [DOI:10.1158/1538-7445.am2025-6935]; stage: "In all four cell lines, MYCi975 was more potent than C26-A6 to inhibit cell viability." [DOI:10.1158/1538-7445.am2025-6935]

02

Targets

MTDH (Metadherin)

Beyond the preview

Go deeper on C26-A6.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on C26-A6.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call